UBS Group »

Avalo Therapeutics Ord shares owned by UBS Group

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Avalo Therapeutics Ord

Jan 2024Mar 2024May 2024Jul 2024Sep 2024Nov 2024Jan 20250200k400k600k050k100k
Value ($)Share countHistorical AVTX position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $732k 99k 7.43
2024-09-30 $58k 6.1k 9.50
2024-06-30 $45k 3.6k 12.50
2024-03-31 $170k 7.7k 22.00
2023-12-31 $18 2 9.00

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Avalo Therapeutics Ord

BVF
Ikarian Capital
RA Capital Management
OrbiMed Advisors
Deep Track Capital
Affinity Asset Advisors
Commodore Capital
TCG Crossover Management
Vanguard Group
Boothbay Fund Management
BlackRock
Royal Bank of Canada
Geode Capital Management
UBS Group
Sio Capital Management

View all funds holding Avalo Therapeutics Ord